×

Mylan's Epipen controversy was self-inflicted: WBB Securities

7:28 PM ET Wed, 24 Aug 2016

Mylan hiked prices in the midst of heated U.S. elections where both candidates agreed that drug prices are too high, says WBB Securities' Steve Brozak.